Other substances

(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid on PubChem

Synonyms

BRD-K68548958

 

Structure image - (E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)/C=C/3\C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C


 

Supporting references

Link Tested on Impact factor Notes Publication date
Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19
Small molecule In silico 		in silico 8.99

Computational modelling predicts that the drug interacts with SARS-CoV-2 infection-related signalling pathways.

 Apr/12/2021
Export (.csv)